Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varun Garg

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxelDeborah Toppmeyer, Andrew D Seidman, Michael Pollak, et al.
Clinical and Translational Science|January 30, 2019
Pharmacokinetic and Drug-Drug Interaction Profiles of the Combination of Tezacaftor/IvacaftorVarun Garg, Jinshan Shen, Chonghua Li, et al.
Plos Computational Biology|April 27, 2010
A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variantsBambang S Adiwijaya, Eva Herrmann, Brian Hare, et al.
Journal of Advanced Pharmaceutical Technology & Research|November 30, 2017
Novel biorelevant dissolution medium as a prognostic tool for polysaccharide-based colon-targeted drug delivery systemAnkit Kumar Yadav, Manik Sadora, Sachin Kumar Singh, et al.
Assay and Drug Development Technologies|May 18, 2019
Coadministration of Polypeptide-k and Curcumin Through Solid Self-Nanoemulsifying Drug Delivery System for Better Therapeutic Effect Against Diabetes Mellitus: Formulation, Optimization, Biopharmaceutical Characterization, and Pharmacodynamic AssessmentVarun Garg, Puneet Kaur, Monica Gulati, et al.
AAPS Pharmscitech|February 9, 2017
Stable Co-crystals of Glipizide with Enhanced Dissolution Profiles: Preparation and CharacterizationNarendra Kumar Pandey, Hans Raj Sehal, Varun Garg, et al.
Blood|September 2, 2020
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndromeDavid C Dale, Frank Firkin, Audrey Anna Bolyard, et al.
Cancer Chemotherapy and Pharmacology|May 2, 2003
Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancerRandall P Rago, Albert Einstein, Richard Lush, et al.
Annals of Internal Medicine|May 21, 2013
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trialMark S Sulkowski, Kenneth E Sherman, Douglas T Dieterich, et al.
Circulation. Arrhythmia and Electrophysiology|March 25, 2022
New-Onset Atrial Fibrillation in Left Bundle Branch Area Pacing Compared With Right Ventricular PacingVenkatesh Ravi, Parikshit S Sharma, Neil R Patel, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxelDeborah Toppmeyer, Andrew D Seidman, Michael Pollak, et al.
Clinical and Translational Science|January 30, 2019
Pharmacokinetic and Drug-Drug Interaction Profiles of the Combination of Tezacaftor/IvacaftorVarun Garg, Jinshan Shen, Chonghua Li, et al.
Plos Computational Biology|April 27, 2010
A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variantsBambang S Adiwijaya, Eva Herrmann, Brian Hare, et al.
Journal of Advanced Pharmaceutical Technology & Research|November 30, 2017
Novel biorelevant dissolution medium as a prognostic tool for polysaccharide-based colon-targeted drug delivery systemAnkit Kumar Yadav, Manik Sadora, Sachin Kumar Singh, et al.
Assay and Drug Development Technologies|May 18, 2019
Coadministration of Polypeptide-k and Curcumin Through Solid Self-Nanoemulsifying Drug Delivery System for Better Therapeutic Effect Against Diabetes Mellitus: Formulation, Optimization, Biopharmaceutical Characterization, and Pharmacodynamic AssessmentVarun Garg, Puneet Kaur, Monica Gulati, et al.
AAPS Pharmscitech|February 9, 2017
Stable Co-crystals of Glipizide with Enhanced Dissolution Profiles: Preparation and CharacterizationNarendra Kumar Pandey, Hans Raj Sehal, Varun Garg, et al.
Blood|September 2, 2020
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndromeDavid C Dale, Frank Firkin, Audrey Anna Bolyard, et al.
Cancer Chemotherapy and Pharmacology|May 2, 2003
Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancerRandall P Rago, Albert Einstein, Richard Lush, et al.
Annals of Internal Medicine|May 21, 2013
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trialMark S Sulkowski, Kenneth E Sherman, Douglas T Dieterich, et al.
Circulation. Arrhythmia and Electrophysiology|March 25, 2022
New-Onset Atrial Fibrillation in Left Bundle Branch Area Pacing Compared With Right Ventricular PacingVenkatesh Ravi, Parikshit S Sharma, Neil R Patel, et al.
Pageof 8